Suivre
Xiaozhe Xiong
Xiaozhe Xiong
Postdoctoral Fellow
Adresse e-mail validée de childrens.harvard.edu
Titre
Citée par
Citée par
Année
Selective recognition of histone crotonylation by double PHD fingers of MOZ and DPF2
X Xiong, T Panchenko, S Yang, S Zhao, P Yan, W Zhang, W Xie, Y Li, ...
Nature chemical biology 12 (12), 1111-1118, 2016
1742016
The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling
Q Zhou, H Lin, S Wang, S Wang, Y Ran, Y Liu, W Ye, X Xiong, B Zhong, ...
Cell host & microbe 16 (4), 450-461, 2014
1362014
YEATS domain—A histone acylation reader in health and disease
D Zhao, Y Li, X Xiong, Z Chen, H Li
Journal of Molecular Biology 429 (13), 1994-2002, 2017
942017
Phage-assisted evolution of botulinum neurotoxin proteases with reprogrammed specificity
TR Blum, H Liu, MS Packer, X Xiong, PG Lee, S Zhang, M Richter, ...
Science 371 (6531), 803-810, 2021
592021
The BAH domain of BAHD1 is a histone H3K27me3 reader
D Zhao, X Zhang, H Guan, X Xiong, X Shi, H Deng, H Li
Protein & cell 7 (3), 222-226, 2016
482016
Emerging enterococcus pore-forming toxins with MHC/HLA-I as receptors
X Xiong, S Tian, P Yang, F Lebreton, H Bao, K Sheng, L Yin, P Chen, ...
Cell 185 (7), 1157-1171. e22, 2022
272022
Multifaceted histone H3 methylation and phosphorylation readout by the plant homeodomain finger of human nuclear antigen Sp100C
X Zhang, D Zhao, X Xiong, Z He, H Li
Journal of Biological Chemistry 291 (24), 12786-12798, 2016
252016
RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition
L Fang, D Ford-Roshon, M Russo, C O’Brien, X Xiong, C Gurjao, ...
Nature communications 13 (1), 3181, 2022
232022
Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
S Tian, X Xiong, J Zeng, S Wang, BJM Tremblay, P Chen, B Chen, M Liu, ...
Nature communications 13 (1), 6786, 2022
122022
RNF43 G659fs is an oncogenic and immune-modulating colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.
M Giannakis, L Fang, D Ford-Roshon, M Russo, C O'Brien, X Xiong, ...
CANCER RESEARCH 82 (23), 2022
2022
Abstract PR009: RNF43 G659fs is an oncogenic and immune-modulating colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition
M Giannakis, L Fang, D Ford-Roshon, M Russo, C O'Brien, X Xiong, ...
Cancer Research 82 (23_Supplement_1), PR009-PR009, 2022
2022
Phage-Assisted Evolution of Botulinum Neurotoxin Proteases With Reprogrammed Specificity
TR Blum, H Liu, MS Packer, X Xiong, PG Lee, S Zhang, M Richter, ...
Toxicon 214, S9, 2022
2022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–12